DeLuca Richard R. Insider Trading Activity (MRK)

Summary

Updated Jul 16, 2026

DeLuca Richard R. has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $4.56M.

Profile

Richard R. DeLuca is identified in SEC filings dated 2026-05-07 as Executive Vice President and President of Merck Animal Health at Merck & Co. This role places him at the helm of Merck's global animal health business. Public SEC documentation confirms his position within Merck & Co., but additional publicly available biographical details beyond the SEC filing are limited in widely accessible sources.

Role	EVP&Pres, Merck Animal Heallth
Notability	60/100

Board memberships

Merck & Co., Inc.

Awards & honors

Leading the Merck Animal Health business unit as EVP & President
Overseeing global strategy and operations for Merck's animal health portfolio

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-05-01	MRK	Merck & Co., Inc.	F — Tax withholding / forfeiture	1.2K	$110.03	$137K
2026-05-01	MRK	Merck & Co., Inc.	M — Option exercise	2.5K	$110.03	$277K
2026-02-06	MRK	Merck & Co., Inc.	S — Open-market sale	37.7K	$120.92	$4.56M
2026-01-28	MRK	Merck & Co., Inc.	A — Grant or award	12.3K	$107.40	$1.32M

Frequently Asked Questions

Who is DeLuca Richard R.?

How many SEC Form 4 filings has DeLuca Richard R. submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has DeLuca Richard R. been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 1 open-market sales ($4.56M) across all tracked filings.

Where can I see all of DeLuca Richard R.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

DeLuca Richard R. — SEC Form 4 Insider Trading Activity